Particle Sciences has established a strategic alliance with Horiba Instruments. Particle Sciences will offer the full array of Horiba characterization tools, while Horiba willbe able to refer clients for cGLP/cGMP development and characterization.
Dr. Robert Lee, vice president of Pharmaceutical Development at Particle Sciences stated, "The need for particle size analysis and physical characterization in general is growing rapidly within this highly regulated environment. Particle Sciences is a world leader in particulate formulations and drug/device combination products. We looked for a partner that shared the same commitment to quality and innovation and Horiba fit the bill."
Dr. Mike Pohl, Horiba's vice president, commented, "Our client base ranges from startups to the largest multinational pharma and biotech companies. For a variety of reasons, we are often asked if we can recommend a site familiar with pharmaceutical development at which they could have work performed. We have worked with Particle Sciences for some time and have been impressed with their facility and their team. By entering into this relationship, we can ensure that our clients not only gain access to the most advanced technology, but also that the operators are highly trained to use the instruments to their fullest capability."